US4812448A
(en)
*
|
1984-10-22 |
1989-03-14 |
Knepper Paul A |
Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
|
US5446177A
(en)
*
|
1984-12-28 |
1995-08-29 |
Alcon Laboratories, Inc. |
Anti-inflammatory compounds for ophthalmic use
|
US5223493A
(en)
*
|
1984-12-28 |
1993-06-29 |
Alcon Laboratories, Inc. |
Anti-inflammatory compounds for ophthalmic use
|
US5358943A
(en)
*
|
1987-12-29 |
1994-10-25 |
Clark Abbot F |
Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
|
US5407926A
(en)
*
|
1987-12-29 |
1995-04-18 |
Alcon Laboratories, Inc. |
Ophthalmic composition
|
US4876250A
(en)
*
|
1988-10-31 |
1989-10-24 |
Alcon Laboratories, Inc. |
Methods for controlling ocular hypertension with angiostatic steroids
|
US4945089A
(en)
*
|
1987-12-29 |
1990-07-31 |
Alcon Laboratories, Inc. |
Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
|
US5371078A
(en)
*
|
1988-10-31 |
1994-12-06 |
Alcon Laboratories, Inc. |
Angiostatic steroids and methods and compositions for controlling ocular hypertension
|
US5919465A
(en)
*
|
1989-09-25 |
1999-07-06 |
University Of Utah Research Foundation |
Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S)
|
DK0494224T3
(da)
*
|
1989-09-25 |
2000-08-07 |
Univ Utah Res Found |
Anvendelse af steroidhormoner i sammensætninger til induktion af T-cellelymfokinproduktion
|
USRE34578E
(en)
*
|
1990-05-07 |
1994-04-05 |
Lubkin; Virginia |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
|
US5041434A
(en)
*
|
1991-08-17 |
1991-08-20 |
Virginia Lubkin |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
|
EP0593520B1
(fr)
*
|
1991-06-18 |
1999-09-29 |
Laboratoire Theramex S.A. |
Compositions oculaires contenant des steroides et leur utilisation pour le traitement du glaucome
|
FR2679139B1
(fr)
*
|
1991-07-17 |
1995-03-17 |
Theramex |
Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
|
EP0614463B1
(en)
*
|
1991-11-22 |
2003-02-12 |
Alcon Laboratories, Inc. |
Angiostatic steroids
|
US6107289A
(en)
*
|
1992-04-21 |
2000-08-22 |
The Schepens Eye Research Institute, Inc. |
Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
|
JPH07508716A
(ja)
*
|
1992-04-21 |
1995-09-28 |
ザ スキーペンズ アイ リサーチ インスティテュート,インコーポレイテッド |
シェーグレン症候群における眼のアンドロゲン療法
|
US5420120A
(en)
*
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
US5646136A
(en)
*
|
1994-01-04 |
1997-07-08 |
Duke University |
Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
|
US5849879A
(en)
*
|
1994-11-03 |
1998-12-15 |
The Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5789169A
(en)
*
|
1994-11-03 |
1998-08-04 |
Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5606043A
(en)
|
1994-11-03 |
1997-02-25 |
The Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
AU7622898A
(en)
*
|
1996-12-05 |
1998-06-29 |
Fenichel, Gerald |
The use of oxandrolone in the treatment of a neurological disorder
|
US6475724B1
(en)
*
|
1997-01-28 |
2002-11-05 |
The Regents Of The University Of California |
Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6171788B1
(en)
|
1997-01-28 |
2001-01-09 |
The Regents Of The University Of California |
Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US7138511B1
(en)
|
1997-01-28 |
2006-11-21 |
The Regents Of The University Of California |
Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6090798A
(en)
*
|
1997-12-19 |
2000-07-18 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with glucocorticoid antagonists
|
US6113542A
(en)
*
|
1998-12-15 |
2000-09-05 |
Hyman; George F. |
Diagnostic apparatus and method to provide effective intraocular pressure based on measured thickness of the cornea
|
US6410045B1
(en)
|
1999-02-22 |
2002-06-25 |
Clyde Lewis Schultz |
Drug delivery system for antiglaucomatous medication
|
US20020197300A1
(en)
*
|
1999-02-22 |
2002-12-26 |
Schultz Clyde L. |
Drug delivery system for anti-glaucomatous medication
|
US20030119000A1
(en)
*
|
2001-11-05 |
2003-06-26 |
Jon Polansky |
Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
|
EP1503730A4
(en)
*
|
2002-04-25 |
2005-09-28 |
Rapidheal Inc |
SYSTEM FOR DELIVERING A GROWTH FACTOR FOR HEALING WOUNDS AND FOR PREVENTING INFLAMMATORY DISEASE AND DISEASE
|
US20030203032A1
(en)
*
|
2002-04-25 |
2003-10-30 |
Schultz Clyde L. |
Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
|
US20050255144A1
(en)
*
|
2003-04-09 |
2005-11-17 |
Directcontact Llc |
Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
|
US20050074497A1
(en)
*
|
2003-04-09 |
2005-04-07 |
Schultz Clyde L. |
Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
|
US9216106B2
(en)
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
AU2004229291A1
(en)
*
|
2003-04-18 |
2004-10-28 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
WO2004093882A1
(ja)
*
|
2003-04-18 |
2004-11-04 |
Advanced Medicine Research Institute |
眼に適用する疾患治療剤
|
EP2298892A3
(en)
|
2004-08-23 |
2011-11-16 |
Sylentis S.A.U. |
Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs
|
WO2007009087A2
(en)
|
2005-07-12 |
2007-01-18 |
Dmi Biosciences, Inc. |
Methods and products for treatment of diseases
|
GB0521351D0
(en)
*
|
2005-10-20 |
2005-11-30 |
Genomica Sau |
Modulation of TRPV expression levels
|
GB0521716D0
(en)
*
|
2005-10-25 |
2005-11-30 |
Genomica Sau |
Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
|
US20080132475A1
(en)
*
|
2006-12-05 |
2008-06-05 |
Charles Gerald Connor |
Treatment for dry eye
|
US20100016264A1
(en)
*
|
2007-12-05 |
2010-01-21 |
Connor Charles G |
Treatment for dry eye using testosterone and progestagen
|
PT2554174E
(pt)
|
2009-06-22 |
2015-12-15 |
Ampio Pharmaceuticals Inc |
Método para o tratamento de doenças
|
WO2012085005A1
(en)
|
2010-12-23 |
2012-06-28 |
Laurent Alexandre |
Method to obtain optical means adapted to a human individual suffering or susceptible to suffer from one or more genetic related eye disorder(s) or disease(s)
|
GB201215857D0
(en)
|
2012-09-05 |
2012-10-24 |
Sylentis Sau |
siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
|
MX368084B
(es)
|
2012-09-05 |
2019-09-19 |
Sylentis Sau |
siRNA Y SU USO EN LA PREPARACIÓN DE UN MEDICAMENTO PARA USARSE EN UN MÉTODO PARA EL TRATAMIENTO DE UN TRANSTORNO OCULAR.
|
SG10201705044YA
(en)
|
2012-12-19 |
2017-07-28 |
Ampio Pharmaceuticals Inc |
Method for treatment of diseases
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
US10011837B2
(en)
|
2014-03-04 |
2018-07-03 |
Sylentis Sau |
SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions
|
DE102015107307B3
(de)
*
|
2015-05-11 |
2016-09-08 |
Labor L + S Aktiengesellschaft |
Optisches Verfahren zur Gehaltsbestimmung von Hyaluronsäure
|